Study guide
16.2 Vascular Access, Enteral Tubes, Drains & Extravasation Management
BCEMP Board Certified Emergency Medicine Pharmacist Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction, Triage, and Resuscitation Fundamentals
1.1 BCEMP Exam Logistics, Content Outlines & Scoring 1.2 Emergency Triage Systems (ESI) & Pre-Hospital Care Coordination 1.3 Resuscitation Pharmacology, Pharmacokinetics & Vascular Access
2 Chapter 2: Cardiac Arrest and Dysrhythmias
2.1 Adult Cardiac Arrest & ACLS Pharmacotherapy Protocols 2.2 Acute Tachyarrhythmias: Narrow- and Wide-Complex Management 2.3 Symptomatic Bradycardia & Vasoactive Chronotropic Support 2.4 Post-Cardiac Arrest Care & Targeted Temperature Management (TTM)
3 Chapter 3: Shock and Hemodynamic Resuscitation
3.1 Sepsis & Septic Shock: Surviving Sepsis Campaign 2026 Resuscitation 3.2 Cardiogenic & Obstructive Shock, Mechanical Circulatory Support & LVADs 3.3 Hypovolemic & Hemorrhagic Shock Fluid Protocols
4 Chapter 4: Airway Management and Rapid Sequence Intubation (RSI)
4.1 Rapid Sequence Intubation (RSI) Process & Pretreatment Agents 4.2 RSI Induction Agents: Pharmacology, Selection & Dosing 4.3 Neuromuscular Blocking Agents & Post-Intubation Analgosedation
5 Chapter 5: Neurocritical Care and Neurologic Emergencies
5.1 Acute Ischemic Stroke: Thrombolysis & Blood Pressure Control 5.2 Intracranial Hemorrhage & Elevated ICP Pharmacotherapy 5.3 Status Epilepticus: Tiered Emergent Anticonvulsant Therapy 5.4 Traumatic Brain Injury & Spinal Cord Emergencies
6 Chapter 6: Acute Coronary Syndromes and Acute Heart Failure
6.1 Acute Coronary Syndromes: STEMI & NSTE-ACS Pharmacotherapy 6.2 Acute Decompensated Heart Failure & Cardiogenic Pulmonary Edema 6.3 Hypertensive Crises: Emergencies, Urgencies & Target Blood Pressure
7 Chapter 7: Pulmonary and Allergic Emergencies
7.1 Acute Pulmonary Embolism: Risk Stratification & Thrombolytic Therapy 7.2 Severe Asthma Exacerbation & COPD Acute Management 7.3 Anaphylaxis & Severe Allergic Reactions: Acute Epinephrine Protocols
8 Chapter 8: Clinical Toxicology: Approach to Poisoning and Common Overdoses
8.1 Approach to the Poisoned Patient: Poison Centers, Toxidromes, Decontamination & Enhanced Elimination 8.2 Acetaminophen Overdose & N-Acetylcysteine Dosing Strategies 8.3 Salicylate Toxicity & Toxic Alcohol Management (Fomepizole) 8.4 Opioid Toxicity & Sedative-Hypnotic/Alcohol Withdrawal Syndromes 8.5 Beta-Blocker & Calcium Channel Blocker Toxicity (HIET, Calcium, Glucagon)
9 Chapter 9: Toxicology: Specialized Poisonings and Antidotes
9.1 Digoxin, Tricyclic Antidepressants & Anticholinergic Toxicity 9.2 Cyanide, Carbon Monoxide & Organophosphate/Cholinergic Toxins 9.3 Snake and Spider Envenomations & Heavy Metal Chelation 9.4 Additional Antidotes: Methemoglobinemia, Isoniazid, Sulfonylureas, Valproate, Sympathomimetics & LAST
10 Chapter 10: Hemostasis, Anticoagulant Reversal, and Hematology
10.1 DOAC & Warfarin Reversal: Specific Reversal Agents & 4F-PCC 10.2 Heparin-Induced Thrombocytopenia (HIT) & Direct Thrombin Inhibitors 10.3 Sickle Cell Vaso-Occlusive Crises & Acute Chest Syndrome
11 Chapter 11: Endocrine, Electrolyte, and Metabolic Emergencies
11.1 Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) 11.2 Severe Electrolyte Emergencies: Hyperkalemia & Hyponatremia 11.3 Endocrine Crises: Thyroid Storm, Myxedema Coma & Acute Adrenal Crisis 11.4 Acute Kidney Injury, Dialyzability & Drug Dosing during RRT
12 Chapter 12: Infectious Diseases and Antimicrobial Stewardship
12.1 Severe Community & Hospital-Acquired Infections in the ED 12.2 Skin & Soft Tissue, STI, and Vector-Borne Emergencies 12.3 ED Antimicrobial Stewardship & Rapid Microbiologic Diagnostics
13 Chapter 13: Special Populations: Pediatrics, Trauma, and Obstetrics
13.1 Pediatric Resuscitation, Status Epilepticus & PALS Pharmacotherapy 13.2 Trauma Pharmacotherapy: Massive Transfusion, TXA, Open Fractures, Tetanus & Burns 13.3 Obstetric & Gynecologic Emergencies: Preeclampsia, Eclampsia & PPH
14 Chapter 14: Medication Safety, ED Operations, and Disaster Preparedness
14.1 ED High-Alert Medications, Error Reporting & Technology Safeguards 14.2 ED Workflow, Transitions of Care & Boarding Patient Management 14.3 Mass Casualty Incidents, CBRNE Countermeasures & Strategic Stockpiles
15 Chapter 15: Biostatistics, Study Design, and Literature Evaluation
15.1 Biostatistics & Hypothesis Testing: Power, Errors & Interpretations 15.2 Clinical Study Designs & Measures of Effect 15.3 Literature Evaluation, Clinical Guidelines & Research Conduct in the ED
16 Chapter 16: Medical Devices, Ventilation, and Medication Delivery
16.1 Mechanical Ventilation, Noninvasive Ventilation & High-Flow Oxygen: What the Pharmacist Must Know 16.2 Vascular Access, Enteral Tubes, Drains & Extravasation Management 16.3 Infusion Pumps, Patient-Owned Devices & Medication Delivery Device Counseling
17 Chapter 17: Organ-System Emergencies: GI, GU, Oncology, Neurology, ENT, Pain, and Psychiatry
17.1 Gastrointestinal & Hepatic Emergencies: GI Bleeding, Cirrhosis Complications, Pancreatitis & Vomiting 17.2 Genitourinary Emergencies: UTI & Pyelonephritis, Renal Colic, Urinary Retention, Priapism & Scrotal Infections 17.3 Oncologic, Immunotherapy & Hematologic Emergencies: Febrile Neutropenia, TLS, Hypercalcemia, irAEs, CAR-T, Hemophilia & TTP 17.4 Headache & Neuromuscular Emergencies: Migraine, Cluster, Myasthenic Crisis, Guillain-Barré & Bell's Palsy 17.5 Ophthalmologic, ENT & Dental Emergencies: Eye Injuries, Angle Closure, Angioedema, Epistaxis, Ear & Throat Infections and Dental Pain 17.6 Acute Pain Management & Procedural Sedation and Analgesia in the ED 17.7 Psychiatric Emergencies: Severe Agitation, Serotonin Syndrome, NMS, Lithium Toxicity & Psychotropic Overdose
18 Chapter 18: Special Populations, Medication Access, and Professional Practice
18.1 Pharmacogenomics, Adverse Drug Events & High-Risk Drug Interactions in Emergency Care 18.2 Special Populations: Older Adults, Extremes of Weight, Pregnancy & Lactation, and Immunocompromised Patients 18.3 Social Determinants of Health, Health Literacy & Medication Access at ED Discharge 18.4 Healthcare Regulations & Standards: FDA, REMS, Bar Coding, DEA, CMS, EMTALA, The Joint Commission, NIOSH & USP 18.5 Formulary & Inventory Management, Drug Shortages, Antidote Stocking & Clinical Decision Support 18.6 Quality Improvement, Practice Standards & Interprofessional Collaboration (Protocols, Teamwork & Debriefing)
16.2 Vascular Access, Enteral Tubes, Drains & Extravasation Management
Key Takeaways Explain This Topic AI
Flow through a catheter rises with the fourth power of its radius and falls with its length, so a short 14 to 16 G peripheral line outruns the lumen of a long central venous catheter.
Vasopressor extravasation is treated with phentolamine 5 to 10 mg diluted in 10 mL of normal saline, injected subcutaneously around the site, ideally within 12 hours.
Hemodialysis catheter lumens are locked with concentrated heparin or citrate, and the lock must be withdrawn and discarded before the lumen is used for anything else.
Arterial lines are for monitoring and blood sampling only; injecting a drug into one can cause limb ischemia.
Medications given through enteral tubes are given one at a time with 15 to 30 mL water flushes, and extended-release, enteric-coated or hazardous products are not crushed.
Last updated: October 2026
16.2 Vascular Access, Enteral Tubes, Drains & Extravasation Management
Note
Exam scope: 2025 outline subtopics 1B4 (Lines, Tubes, and Drains) and 2C1 (Medication Preparation and Delivery). Intraosseous access and the cardiac arrest access hierarchy are covered in Section 1.3; infusion pumps and patient devices are covered in Section 16.3.
Peripheral Catheters and Flow Physics
The Hagen-Poiseuille relationship explains why access choice matters in hemorrhage: flow is proportional to the fourth power of the radius and inversely proportional to catheter length . Halving the radius cuts flow sixteen-fold.
Practical consequences:
A short 14 or 16 G peripheral catheter gives faster flow than the 16 G distal lumen of a 20-cm triple-lumen central line.
For massive transfusion, use large-bore peripheral lines, a rapid infusion catheter, or an introducer sheath (8.5 to 9 Fr) connected to a rapid infuser.
A pressure bag cannot make up for a 22 G catheter.
Viscous fluids such as packed red cells flow more slowly than crystalloid through the same catheter.
Peripheral Administration of Vasopressors and Irritant Drugs
The Surviving Sepsis Campaign suggests starting vasopressors peripherally rather than delaying them until a central line is placed . Institutional protocols usually require:
A catheter of 20 G or larger in a large vein at or above the antecubital fossa, often placed with ultrasound and checked for blood return.
Limits on concentration and duration, with a plan to place central access if therapy continues.
Site checks every 1 to 2 hours by nursing staff, with stop-and-treat instructions for extravasation.
Observational data show that extravasation is uncommon and rarely causes lasting tissue injury when such protocols are followed.
Common Vesicants and Irritants in the ED
- Drug or solution Concern
- Norepinephrine, epinephrine, dopamine, phenylephrine, vasopressin Vasoconstriction causing ischemic necrosis
- Calcium chloride (more than gluconate) Hyperosmolar, causes tissue calcification and necrosis
- Dextrose 50%, hypertonic saline above 3%, sodium bicarbonate 8.4% Hyperosmolar injury
- Potassium chloride in high concentration Pain, phlebitis and necrosis; concentration limits apply peripherally
- Phenytoin pH around 12; "purple glove syndrome"
Promethazine Severe tissue injury and gangrene; FDA's 2023 labeling prefers deep IM injection, and IV use requires dilution and infusion
- Acyclovir, vancomycin, radiocontrast Irritants causing phlebitis or injury at high concentration
- Anthracyclines, vinca alkaloids Chemotherapy vesicants
Parenteral nutrition above about 900 mOsm/L needs central access (ASPEN), and 23.4% saline is given only centrally.
Extravasation Management
General steps: stop the infusion, leave the catheter in place and aspirate what you can, mark the borders, elevate the limb , then remove the catheter and give the specific antidote. Photograph the site, document it, and arrange follow-up for any blistering or necrosis.
Extravasated agent Antidote Thermal therapy
Vasopressors Phentolamine 5 to 10 mg in 10 mL normal saline , injected subcutaneously in small aliquots around the site, ideally within 12 hours. Children: 0.1 to 0.2 mg/kg (maximum 10 mg). Topical nitroglycerin or subcutaneous terbutaline are alternatives during shortages Avoid cold, which adds vasoconstriction
Hyperosmolar solutions, calcium, contrast, dextrose Hyaluronidase , commonly 150 units as several small subcutaneous injections around the site Warm compresses to help dispersion
Vinca alkaloids (vincristine, vinblastine) Hyaluronidase Warm compresses
Anthracyclines (doxorubicin, daunorubicin) Dexrazoxane IV within 6 hours, in the opposite limb: 1,000 mg/m2 on days 1 and 2, then 500 mg/m2 on day 3 Cold compresses, removed 15 minutes before dexrazoxane
Tip
Warm compresses disperse drugs that are safer spread out (vinca alkaloids, hyperosmolar solutions). Cold compresses keep drugs that are dangerous in tissue localized (anthracyclines). Do not combine topical dimethyl sulfoxide with dexrazoxane.
- Central Venous, Dialysis, Port and Arterial Lines
- Multi-Lumen Central Venous Catheters
A typical 7 Fr triple-lumen catheter has a larger distal lumen (about 16 G) and two smaller lumens (about 18 G). Pharmacist checks include:
A dedicated lumen for vasopressors. A bolus pushed through the vasopressor lumen flushes the drug in the dead space into the patient as an unintended pressor bolus.
Y-site compatibility. Phenytoin precipitates with dextrose, ceftriaxone must never be mixed with calcium-containing solutions in neonates, and propofol's lipid emulsion limits co-infusion.
Line infection prevention. Use chlorhexidine-alcohol skin preparation and full barrier precautions at insertion, scrub the hub before every access, and remove lines that are no longer needed.
Hemodialysis Catheters
Dialysis catheter lumens are locked between treatments with concentrated heparin (often 1,000 to 5,000 units/mL) or citrate, filling the lumen volume printed on the hub. Using the line without first withdrawing and discarding the lock gives the patient an unplanned heparin bolus that can reach thousands of units. These lines are reserved for dialysis except in emergencies, and only after the lock is removed.
Implanted Ports and PICCs
Implanted ports are accessed with a non-coring (Huber) needle under sterile technique and flushed according to policy. PICCs can be used for most medications once the tip position is confirmed, but small lumens limit rapid infusion.
Arterial Lines
Arterial catheters are for continuous pressure monitoring and blood sampling. Never inject medications into them. Accidental intra-arterial injection of drugs such as promethazine, benzodiazepines or barbiturates can cause severe vasospasm and limb ischemia. Clear line labeling and distinct tubing prevent mix-ups.
Medication Administration Through Enteral Tubes
Do not crush extended-release, enteric-coated, sublingual or buccal products, or hazardous drugs. Use the ISMP "Do Not Crush" list and switch to an immediate-release or liquid product with adjusted dosing.
Give each medication separately and flush with 15 to 30 mL of water before, between and after doses. Dilute hypertonic or sorbitol-containing liquids, which cause diarrhea.
Check tube position. Jejunal tubes bypass the stomach, which matters for drugs that need gastric acid or act in the stomach.
Drug-feed interactions:
Phenytoin absorption falls with continuous feeds. Hold feeds 1 to 2 hours before and after each dose where policy supports it, and follow levels.
Fluoroquinolones and tetracyclines chelate with divalent cations in feeds; separate them or choose another route.
Levothyroxine and warfarin also need consistent timing relative to feeds.
Carbamazepine suspension binds to PVC tubing, so dilute it and flush well.
Clogged tubes: start with warm water. If that fails, use non-enteric-coated pancreatic enzyme with sodium bicarbonate dissolved in water. Avoid cola and acidic juices.
Chest Tubes and Other Drains
Pleural infection: intrapleural alteplase 10 mg plus dornase alfa 5 mg twice daily for 3 days (MIST2, 2011) improved drainage and reduced referral for surgery compared with either agent alone or placebo.
Procedural analgesia: local anesthetic infiltration within maximum doses (Section 9.4), supplemented by procedural sedation (Section 17.6).
External ventricular drains:
For ventriculitis that responds poorly to IV therapy, IDSA (2017) allows intraventricular antibiotics , such as preservative-free vancomycin (5 to 20 mg) or gentamicin (4 to 8 mg) in adults, with the drain clamped for 15 to 60 minutes.
Intraventricular alteplase 1 mg every 8 hours for intraventricular hemorrhage (CLEAR III, 2016) lowered mortality but did not improve the primary functional outcome.
Only preservative-free products in small volumes may be given intrathecally or intraventricularly.
Urinary catheters: remove them as soon as possible to prevent catheter-associated infection, and do not treat asymptomatic bacteriuria in catheterized patients (Section 17.2).